NYSE:GMRE (USA)

Global Medical REIT Inc

$ 10.53 -0.11 (-1.03%)
Volume: 48,307 Avg Vol (1m): 315,083
Market Cap $: 364.90 Mil Enterprise Value $: 727.00 Mil
P/E (TTM): 30.17 P/B: 1.12
Earnings Power Value -41.09
Net Current Asset Value -13.92
Tangible Book 9.69
Projected FCF 3.45
Median P/S Value 10.64
Graham Number 8.7
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 4.4/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.01
Cash-To-Debt range over the past 10 years
Min: 0.01, Med: 0.05, Max: 10000
Current: 0.01
0.01
10000
Equity-to-Asset 0.52
Equity-to-Asset range over the past 10 years
Min: 0, Med: 0.4, Max: 0.78
Current: 0.52
0
0.78
Debt-to-Equity 0.76
Debt-to-Equity range over the past 10 years
Min: -456.94, Med: 1.17, Max: 47.85
Current: 0.76
-456.94
47.85
Debt-to-EBITDA 5.23
Debt-to-EBITDA range over the past 10 years
Min: -87.48, Med: 11.57, Max: 410.77
Current: 5.23
-87.48
410.77
Interest Coverage 1.45
Interest Coverage range over the past 10 years
Min: 0.03, Med: 1.49, Max: 10000
Current: 1.45
0.03
10000
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.91
DISTRESS
GREY
SAFE
Beneish M-Score -1.23
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 4.04%
WACC 5.09%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 41.55
Operating Margin range over the past 10 years
Min: -93.16, Med: 26.04, Max: 41.82
Current: 41.55
-93.16
41.82
Net Margin % 23.94
Net Margin range over the past 10 years
Min: -171.58, Med: -77.37, Max: 25.36
Current: 23.94
-171.58
25.36
ROE % 2.93
ROE range over the past 10 years
Min: -169.49, Med: -33.67, Max: 2.97
Current: 2.93
-169.49
2.97
ROA % 2.24
ROA range over the past 10 years
Min: -562.5, Med: -4.34, Max: 2.44
Current: 2.24
-562.5
2.44
3-Year Total Revenue Growth Rate 195.50
3-Year Revenue Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: -33.5
Current: -33.5
0
-33.5
3-Year Total EBITDA Growth Rate 334.60
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: -2.2
Current: -2.2
0
-2.2

» GMRE's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:GMRE

» Interactive Chart

Peter Lynch Chart

Business Description

Industry REITs » REITs    NAICS : 525920    SIC : 6798
Compare NYSE:MRT XKLS:5116 TSE:3455 SGX:AW9U TSE:3308 NZSE:VHP NYSE:CHCT OTCPK:GBCS TSXV:PT TSX:NWH.UN NYSE:UHT SGX:C2PU NYSE:LTC LSE:AGR NAS:SNH NAS:CTRE TSX:CSH.UN NYSE:GEO NYSE:NHI NYSE:DOC
Traded in other countries
Address 2 Bethesda Metro Center, Suite 440, Bethesda, MD, USA, 20814
Global Medical REIT Inc is a United States-based company engaged primarily in the acquisition and leasing of licensed, purpose-built healthcare facilities in select markets with clinical operators with dominant market share. The company seeks to invest in these purpose-built, specialized facilities, such as surgery centers, specialty hospitals, and outpatient treatment centers. The company's healthcare facilities are typically leased, or under contract to be leased, under long-term triple-net leases on the date of purchase. It is externally managed and advised by Inter-American Management LLC, which is an entity owned or controlled by an affiliate of ZH USA, LLC.

Ratios

Current vs industry vs history
PE Ratio (TTM) 30.17
PE Ratio range over the past 10 years
Min: 25.33, Med: 31.41, Max: 566.87
Current: 30.17
25.33
566.87
PE Ratio without NRI 30.17
PE without NRI range over the past 10 years
Min: 25.33, Med: 31.41, Max: 566.87
Current: 30.17
25.33
566.87
PB Ratio 1.12
PB Ratio range over the past 10 years
Min: 0.8, Med: 1.09, Max: 1.31
Current: 1.12
0.8
1.31
PS Ratio 4.36
PS Ratio range over the past 10 years
Min: 1.19, Med: 4.36, Max: 10.46
Current: 4.36
1.19
10.46
Price-to-Free-Cash-Flow 11.41
Price-to-Free-Cash-Flow range over the past 10 years
Min: 7.46, Med: 9.22, Max: 14.62
Current: 11.41
7.46
14.62
Price-to-Operating-Cash-Flow 11.40
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 7.41, Med: 11.21, Max: 53.84
Current: 11.4
7.41
53.84
EV-to-EBIT 23.48
EV-to-EBIT range over the past 10 years
Min: -345.6, Med: 21.4, Max: 164.5
Current: 23.48
-345.6
164.5
EV-to-EBITDA 14.69
EV-to-EBITDA range over the past 10 years
Min: 12.6, Med: 25.75, Max: 1357.2
Current: 14.69
12.6
1357.2
EV-to-Revenue 12.78
EV-to-Revenue range over the past 10 years
Min: 11, Med: 14.7, Max: 28.6
Current: 12.78
11
28.6
Current Ratio 0.75
Current Ratio range over the past 10 years
Min: 0.02, Med: 0.75, Max: 4.63
Current: 0.75
0.02
4.63
Quick Ratio 0.75
Quick Ratio range over the past 10 years
Min: 0.02, Med: 0.75, Max: 4.63
Current: 0.75
0.02
4.63
Days Sales Outstanding 22.86
Days Sales Outstanding range over the past 10 years
Min: 8.47, Med: 9.42, Max: 22.86
Current: 22.86
8.47
22.86
Days Payable 1.00
Days Payable range over the past 10 years
Min: 0, Med: 0, Max: 1
Current: 1
0
1

Dividend & Buy Back

Current vs industry vs history
Dividend Yield % 7.58
Trailing Dividend Yield range over the past 10 years
Min: 7.04, Med: 8.62, Max: 12.14
Current: 7.58
7.04
12.14
Dividend Payout Ratio 2.29
N/A
3-Year Dividend Growth Rate (Per Share) -7.90
3-Year Dividend Growth Rate range over the past 10 years
Min: 0, Med: 0, Max: 111
Current: -7.9
0
111
Forward Dividend Yield % 7.52
N/A
Yield-on-Cost (5-Year) % 7.53
Yield-on-Cost (5y) range over the past 10 years
Min: 7.04, Med: 8.62, Max: 12.14
Current: 7.53
7.04
12.14
3-Year Share Buyback Rate -344.60
3-Year Share Buyback Rate range over the past 10 years
Min: -858.5, Med: -342.3, Max: 0
Current: -344.6
-858.5
0

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 1.09
Price-to-Tangible-Book range over the past 10 years
Min: 0.9, Med: 1.13, Max: 1.32
Current: 1.09
0.9
1.32
Price-to-Projected-FCF 3.06
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 2.85, Med: 5.04, Max: 7.23
Current: 3.06
2.85
7.23
Price-to-Median-PS-Value 0.99
Price-to-Median-PS-Value range over the past 10 years
Min: 0.29, Med: 0.95, Max: 2.1
Current: 0.99
0.29
2.1
Price-to-Graham-Number 1.21
Price-to-Graham-Number range over the past 10 years
Min: 1.09, Med: 2.64, Max: 5.61
Current: 1.21
1.09
5.61
Earnings Yield (Joel Greenblatt) % 4.29
Earnings Yield (Greenblatt) range over the past 10 years
Min: -1.5, Med: 1.6, Max: 5
Current: 4.29
-1.5
5

More Statistics

Revenue (TTM) (Mil) $ 56.83
EPS (TTM) $ 0.35
Beta 0.44
Volatility % 19.01
52-Week Range $ 8.1 - 11.51
Shares Outstanding (Mil) 34.56

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N